Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration

Rothenbuehler, Simon P; Waeber, David; Brinkmann, Christian K; Wolf, Sebastian; Wolf-Schnurrbusch, Ute E K (2009). Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration. American journal of ophthalmology, 147(5), pp. 831-7. New York, N.Y.: Elsevier Science 10.1016/j.ajo.2008.12.005

Full text not available from this repository. (Request a copy)

To demonstrate not only prevention of vision loss but also improvement in best-corrected visual acuity (BCVA) after treatment with ranibizumab on a variable-dosing regimen over 24 months in patients with age-related macular degeneration (AMD).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Ophthalmology

UniBE Contributor:

Brinkmann, Christian Karl; Wolf, Sebastian and Wolf-Schnurrbusch, Ute

ISSN:

0002-9394

ISBN:

19217019

Publisher:

Elsevier Science

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:05

Last Modified:

06 Dec 2013 13:54

Publisher DOI:

10.1016/j.ajo.2008.12.005

PubMed ID:

19217019

Web of Science ID:

000265762900013

URI:

https://boris.unibe.ch/id/eprint/28230 (FactScience: 118928)

Actions (login required)

Edit item Edit item
Provide Feedback